Evotec SE has progressed its strategic partnership with Bristol Myers Squibb, further bolstering the joint pipeline of advanced neuroscience programs, triggering a $25 million payment to further research efforts.   The companies entered a strategic neuroscience collaboration in December 2016 to identify disease-modifying treatments for a broad range of neurodegenerative diseases where there remains a significant unmet medical need to slow down or reverse disease progression.   The partnershi...